Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 03.08.2020
ISRA VISION AG
Atlas Copco starts Squeeze-out procedure
Darmstadt, August 3, 2020 - Today, Atlas Copco Germany Holding AG submitted a formal request to the Executive Board of ISRA VISION AG pursuant to Section 62 (1) and (5) sentence 1 German Transformation Act (UmwG) in conjunction with Sections 327a et seq. German Stock Corporation Act (AktG) to carry out the [ … ]
Mon, 03.08.2020
HYPOPORT SE
Press release
Group results for H1 2020
Hypoport SE generates growth of over 20 per cent, demonstrating the effectiveness of its business models during the coronavirus crisis
- Consolidated revenue rises by 21 per cent year on year to €189 million in the first six months of 2020
- EBIT for the first half of the year climbs by 8 per cent to [ … ]
Mon, 03.08.2020
Nordex SE
Nordex Group announces potential sale of its 2.7 GW European project development pipeline to RWE
The 2.7 GW portfolio includes projects in France, Spain, Sweden and Poland
Strong boost to Nordex's capital structure
Cash consideration of EUR 402.5 million before deduction of any customary fees, taxes and any other adjustments
Further reinforci [ … ]
Mon, 03.08.2020
Polyphor AG
Allschwil, Switzerland, August 3, 2020
Polyphor announces second positive Data Safety Monitoring Board recommendation to continue Phase III FORTRESS study without modifications
Polyphor AG (SIX: POLN) announced today that the Phase III clinical trial independent Data Safety Monitoring Board (DSMB) has completed the second, pre-specified interim a [ … ]
Mon, 03.08.2020
Belimo Holding AG
Hinwil (Switzerland), EMBARGOED UNTIL August 3, 2020, 07:00 a.m. CET
Press Release of the Belimo Group
Belimo: Delivering Strong Performance Thanks to High Product Availability
In the face of an unprecedented crisis, Belimo managed remarkably well in the first half-year of 2020. The Company was able to maintain superior service levels and high p [ … ]
Mon, 03.08.2020
Stabilus S.A.
CORPORATE NEWS
Stabilus S.A.: Stabilus publishes results for the third-quarter of FY2020 and updates full-year forecast
- Revenues in Q3 at EUR 147.0m, after EUR 241.6m in Q3 FY2019
- Positive adjusted EBIT[1] in Q3 at EUR 5.7m, after EUR 37.1m in Q3 FYJ2019
- Q3 result at EUR -16.4m (Q3 FY2019: EUR 19.3m) and free cash flow before acquisition [ … ]
Sun, 02.08.2020
Immunic, Inc.
Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis- Study Meets Primary and Key Secondary Endpoints with High Statistical Significance Indicating Activity for IMU-838 in Relapsing-Remitting Multiple Sclerosis -
- Statistically Significant Reduction of 62% and [ … ]
Sun, 02.08.2020
Siemens Aktiengesellschaft
Munich, August 2, 2020
Disclosure of an inside information according to Article 17 MAR
Siemens welcomes acquisition of Varian by Siemens Healthineers
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG's acquisition of a 100 percent stake in Varian Medical Systems, Inc [ … ]
Sun, 02.08.2020
Siemens Healthineers AG
Siemens Healthineers AG (Frankfurt: SHL) ("Siemens Healthineers") today entered into an agreement with Varian Medical Systems, Inc. (NYSE: VAR) ("Varian"), a global leader in the field of cancer care, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of Vari [ … ]
Sat, 01.08.2020
MorphoSys AG
FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)- First FDA approval of a second-line treatment for adult patients with relapsed or refractory DLBCL, helping fill a high unmet medical need
- FDA granted Monjuvi Fast Tra [ … ]